Current Report Filing (8-k)
13 July 2022 - 7:21AM
Edgar (US Regulatory)
0001444307
false
0001444307
2022-07-12
2022-07-12
iso4217:USD
xbrli:shares
iso4217:USD
xbrli:shares
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
WASHINGTON,
DC 20549
FORM
8-K
CURRENT
REPORT
Pursuant
to Section 13 or 15(d)
of
the Securities Exchange Act of 1934
Date
of Report (Date of earliest event reported): July 12, 2022
ONCOSEC
MEDICAL INCORPORATED
(Exact
Name of Registrant as Specified in Charter)
Nevada |
|
000-54318 |
|
98-0573252 |
(State or Other Jurisdiction
of Incorporation) |
|
(Commission
File Number) |
|
(IRS Employer
Identification No.) |
24
North Main Street, Pennington, NJ |
|
|
|
08534-2218 |
(Address
of Principal Executive Offices) |
|
|
|
(Zip
Code) |
Registrant’s
telephone number, including area code: (855) 662-6732
Check
the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under
any of the following provisions:
☐ |
Written
communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
|
|
☐ |
Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
|
|
☐ |
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
|
|
☐ |
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Securities
registered pursuant to Section 12(b) of the Act:
Title
of each class |
|
Trading
symbol |
|
Name
of each exchange on which registered |
Common
Stock, par value $0.0001 per share |
|
ONCS |
|
Nasdaq
Capital Market |
Indicate
by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405
of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging
growth company ☐
If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item
5.07. Submission of Matters to a Vote of Security Holders.
The
2022 annual meeting of stockholders of OncoSec Medical Incorporated (the “Company”) was held on July 12, 2022 (the “Annual
Meeting”). The following matters were voted on by the stockholders: (i) the election of six directors to the Company’s Board
of Directors and (ii) the ratification of the appointment of Mayer Hoffman McCann P.C. as the Company’s independent registered
public accounting firm for the year ending July 31, 2022. The results of the vote are summarized below.
Item
1: Election of Directors
The
stockholders elected all six nominees at the Annual Meeting to serve as directors until the Company’s Annual Meeting of Stockholders
in 2023. The voting results were as follows:
Nominee | |
For | | |
Withheld | | |
Broker Non-Votes | |
Dr. Linda Shi | |
| 25,310,937 | | |
| 488,071 | | |
| 5,199,133 | |
Dr. James M. DeMesa | |
| 24,615,761 | | |
| 1,183,247 | | |
| 5,199,133 | |
Mr. Joon Kim | |
| 25,725,010 | | |
| 73,998 | | |
| 5,199,133 | |
Dr. Herbert Kim Lyerly | |
| 25,347,771 | | |
| 451,237 | | |
| 5,199,133 | |
Mr. Kevin R. Smith | |
| 24,526,055 | | |
| 1,272,953 | | |
| 5,199,133 | |
Mr. Chao Zhou | |
| 25,297,840 | | |
| 501,168 | | |
| 5,199,133 | |
Item
2: Ratification of the appointment of Mayer Hoffman McCann P.C. as the Company’s independent registered public accounting firm
for the fiscal year ending July 31, 2022
The
stockholders ratified the appointment of Mayer Hoffman McCann P.C. as the Company’s independent registered public accounting firm
for the fiscal year ending July 31, 2022. The voting results were as follows:
For | |
Against | | |
Abstain | | |
Broker Non-Votes | |
30,789,629 | |
| 39,039 | | |
| 169,473 | | |
| N/A | |
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by
the undersigned hereunto duly authorized.
Date:
July 12, 2022 |
OncoSec
Medical Incorporated |
|
|
|
By: |
/s/
Robert H. Arch |
|
Name: |
Robert
H. Arch |
|
Title: |
President
and Chief Executive Officer |
OncoSec Medical (NASDAQ:ONCS)
Historical Stock Chart
From Apr 2024 to May 2024
OncoSec Medical (NASDAQ:ONCS)
Historical Stock Chart
From May 2023 to May 2024
Real-Time news about OncoSec Medical Incorporated (NASDAQ): 0 recent articles
More Oncosec Medical Inc News Articles